ACE — Ascelia Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK71.37m
- SEK33.84m
Brief: Ascelia Pharma Q1 Operating Loss Widens To SEK 33.7 Mln
Brief: Ascelia Pharma Says Carried Out Directed New Share Issue Raising SEK 200 Mln
Brief: Ascelia Pharma AB intends to carry out a directed new share issue
Brief: Ascelia Pharma Opens U.S. Office In Preparation For Mangoral Launch
Brief: Ascelia Q4 Operating Loss Widens To SEK 27.9 Mln
Brief: Ascelia Pharma Says CMC SPV Divests 687,606 Shares In Co Via Private Placement To Institutional Investors
Brief: Ascelia Pharma Gets US Patent For Second Generation Mangoral
Brief: Ascelia Pharma Q3 Operating Loss Widens To SEK 16.3 Mln
Brief: Ascelia Pharma: EMA Confirms Mangoral Eligible For The Centralized Regulatory Procedure In The EU
Brief: Ascelia Pharma Upgrades Estimate Of Addressable Market For Mangoral
Brief: Ascelia Pharma: First Commercial Scale Manufacturing Of Mangoral
Brief: Ascelia Pharma Q2 Oper Loss Widens To SEK 28.6 Mln
Brief: Ascelia Pharma Provides Updated SPARKLE Timelines Due To Covid-19 Impact
Brief: Ascelia Q1 Operating Loss Widens To SEK 20.7 Mln
Brief: Ascelia Pharma Gets Patent For Oncoral In Japan
Brief: Ascelia Pharma Says Is In A Solid Financial Situation With 184 MSEK In Liquidity As Of Beginning Of 2020
Brief: Ascelia Pharma Oct-Dec Operating Loss SEK 22.9 Mln
Brief: Ascelia Pharma Oct-Dec Operating Loss Widens To SEK 22.9 Mln
Brief: Ascelia Pharma Opens Five Sites In Phase III Study